Top Ranked Income Stocks to Buy for April 14th

CFR TD FHB ALX

Here are four stocks with buy rank and strong income characteristics for investors to consider today, April 14th:

The Toronto-Dominion Bank (TD - Free Report) : This Canadian chartered bank that offers a wide range of business and consumer services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 16.2% over the last 60 days.

 

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 3.74%, compared with the industry average of 1.40%. Its five-year average dividend yield is 3.90%.

 

First Hawaiian, Inc. (FHB - Free Report) : This company that offers banking services to consumer and commercial customers has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.6% over the last 60 days.

 

This Zacks Rank #1 company has a dividend yield of 3.84%, compared with the industry average of 1.83%. Its five-year average dividend yield is 3.71%.

 

Alexander's, Inc. (ALX - Free Report) : This real estate investment trust engaged in leasing, managing, developing and redeveloping properties has witnessed the Zacks Consensus Estimate for its current year earnings increasing 31.1% over the last 60 days.

 

This Zacks Rank #1 company has a dividend yield of 6.30%, compared with the industry average of 3.16%. Its five-year average dividend yield is 5.08%.

 

Cullen/Frost Bankers, Inc. (CFR - Free Report) : This bank holding company for Frost Bank has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.8% over the last 60 days.

 

This Zacks Rank #1 company has a dividend yield of 2.64%, compared with the industry average of 1.40%. Its five-year average dividend yield is 2.93%.

 

See the full list of top ranked stocks here.

Find more top income stocks with some of our great premium screens.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>